LY-3390334

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameLY-3390334
Drug Alias NameLY-3390334LY-339840LY-393053LY-367366
ClassificationSmall molecules
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonistsMetabotropic glutamate receptor 1 antagonists
TargetsMetabotropic glutamate receptor 5Metabotropic glutamate receptor 1
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A